Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$66K Buy
160
+56
+54% +$22.5K 0.31% 30
2020
Q2
$26K Buy
+104
New +$38.9K 0.02% 439
2019
Q3
Sell
-699
Closed -$185K 461
2019
Q2
$185K Buy
699
+511
+272% +$130K 0.15% 351
2019
Q1
$50K Sell
188
-345
-65% -$99.4K 0.04% 378
2018
Q4
$153K Buy
+533
New +$169K 0.11% 343
2018
Q3
Sell
-603
Closed -$179K 461
2018
Q2
$179K Sell
603
-18
-3% -$5.27K 0.3% 81
2018
Q1
$167K Buy
621
+517
+497% +$140K 0.21% 275
2017
Q4
$26K Buy
+104
New +$25.7K 0.02% 439

Other funds holding HUM

Cerebellum's HUM Position: Q3 2020 in Review

Cerebellum increased its Humana (HUM) stake by 54% in Q3 2020, buying an estimated $22.5K and bringing the position to 160 shares worth $66K. The position accounts for 0.31% of the portfolio, ranked #30.

Cerebellum first reported a position in HUM in Q4 2017 and has held it in 8 quarters since. The position peaked at $185K in Q2 2019. 847 funds tracked by Wall St. Rank hold HUM as of Q3 2020.

  • Cerebellum held 160 shares of Humana worth $66K as of Q3 2020.
  • Cerebellum bought 56 Humana shares in Q3 2020, an estimated $22.5K.
  • Humana made up 0.31% of Cerebellum's portfolio in Q3 2020, its #30 holding.
  • Cerebellum first reported a position in Humana in Q4 2017 and has held it in 8 quarters since.
  • Cerebellum's Humana position peaked at $185K in Q2 2019.
  • 847 funds tracked by Wall St. Rank held Humana as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.